Is endovenous laser ablation possible while taking warfarin?

Chris Delaney, David Russell, John Iannos, James Spark

    Research output: Contribution to journalArticlepeer-review

    11 Citations (Scopus)


    Purpose: The subgroup of patientswith venous ulcers requiring anticoagulation for co-morbid conditions has traditionally created a therapeutic dilemma. Perioperative management of anticoagulation can be costly and increase the risk of surgical complications. This group of patients is often elderly and shows poor compliance with compression hosiery. The aim of this study was to investigate the outcome of endovenous laser ablation (EVLA) of the great saphenous vein (GSV) in patients remaining on therapeutic anticoagulation. Materials and methods: Fifteen consecutive patients (CEAP [clinical, aetiological, anatomical and pathological elements] classification 5 or 6) were treated with standard GSV EVLA using tumescent anaesthesia and a diode 1470-nm radial laser fibre while maintaining international normalized ratio at therapeutic levels. Clinical and duplex follow-up at six weeks and three, six and 12 months were performed. Results: The GSV was successfully occluded in 14/15 (93%) of patients. The remaining patient had a second successful treatment three months later. No significant complications requiring intervention were encountered. Conclusion: EVLA using the diode 1470-nm radial fibre is efficacious with minimal complications in patients therapeutically anticoagulated. This treatment should be added to the armamentarium in this problematic patient group.

    Original languageEnglish
    Pages (from-to)231-234
    Number of pages4
    Issue number5
    Publication statusPublished - Aug 2012


    • Ablation
    • Endovascular treatment
    • Laser treatment
    • Vein
    • Venous intervention


    Dive into the research topics of 'Is endovenous laser ablation possible while taking warfarin?'. Together they form a unique fingerprint.

    Cite this